DOI: 10.1055/s-00023610

Drug Research

Issue 06 · Volume 64 · June 2014 DOI: 10.1055/s-004-27111

Original Article

  • 281
    Sheikhi, A.; Saadati, K.; Jafarzadeh, A.; Karimi, H.; Mousavinasab, N.:

    Augmenting the Expression of NKp44 Molecule and the Natural Killer Activity in Peripheral Blood Mononuclear Cells from Patients with Malignant Colorectal Carcinoma

  • 287
    Rani, S.; Sharma, S.; Kumar, S.:

    To Investigate Antihyperglycemic and Antihyperlipidemic Potential of Safrole in Rodents by in-vivo and in-vitro Study

  • 296
    Liu, M.; Wang, X. L.; Zhang, D.; Yang, M.; Han, J.; Zhang, Y. N.; Wang, Z. L.; Liu, H. C.:

    Pharmacokinetics of Niacin, Simvastatin and their Metabolites in Healthy Chinese Subjects after Single and Multiple Doses of a Fixed Dose Combination Tablet of Niacin Extended Release/Simvastatin

  • 301
    Lari, P.; Rashedinia, M.; Abnous, K.; Hosseinzadeh, H.:

    Crocin Improves Lipid Dysregulation in Subacute Diazinon Exposure through ERK1/2 Pathway in Rat Liver

  • 306
    Paliwal, N.; Jain, P.; Dubey, N.; Sharma, S.; Khurana, S.; Kumar Paliwal, S.:

    A Liquid Chromatography Tandem Mass Spectrometry Based Regulatory Compliant Method for the Determination of Tenofovir in Human Serum

  • 313
    Ghorab, M. M.; Al-Dhfyan, A.; Al-Dosari, M. S.; El-Gazzar, M. G.; AlSaid, M. S.:

    Antiproliferative Activity of Novel Thiophene and Thienopyrimidine Derivatives

  • 321
    Chaursia, B. K.; Singh, T. P.; Varshney, B.; Sharma, P.; Iyer, S. S.; Khuroo, A. H.; Monif, T.:

    Development and Validation of Liquid Chromato­graphy-Tandem Mass Spectrometric Method for Quantification of Meropenem in Rat Plasma and its Application in a Preclinical Dose Proportionality Study

  • 330
    Qiu, X.-j; Zheng, S.-l.; Wang, Y.-f.; Wang, R.; Ye, L.:

    Rapid and Sensitive UPLC-MS/MS Method for the Determination of Domperidone in Human Plasma and its Application to Pharmacokinetic Study

    • Letter

  • 335
    Srinivas, N. R.:

    Dilemma with Matrix Effect in Bioanalysis – Perspectives from Bioavailability/Bioequivalence Studies for Product Registration?